We conducted meta-analyses comparing non-progressive MCI (stable MCI) with progressive MCI (MCI_AD) for each of the three analytes (amyloid beta 1-42, ‘amyloid’; T-tau, and P-tau), and did likewise to compare healthy controls (HC) with MCI_AD. Here, MAPT is linked to Alzheimer disease.